View More View Less
  • 1
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $1,070.00

Az elmúlt másfél évtized kutatásai bebizonyították, hogy a zsírszövet aktív endokrin szerv, amely számos hormont választ el. A szerzők a leptin, az adiponektin, a rezisztin, a visfatin és az omentin hormonok működését mutatják be, különös tekintettel az anyagcsere-folyamatokra gyakorolt hatásukra.

  • Fischer-Posovszky, P., Wabitsch, M., Hochberg, Z.: Endocrinology of adipose tissue–an update. Horm. Metab. Res., 2007, 39 , 314–321.

    Hochberg Z. , 'Endocrinology of adipose tissue–an update ' (2007 ) 39 Horm. Metab. Res. : 314 -321.

    • Search Google Scholar
  • Frühbeck, G.: Overview of adipose tissue and its role in obesity and metabolic disorders. Methods in Molecular Biology, 2008, 456 , 1–22.

    Frühbeck G. , 'Overview of adipose tissue and its role in obesity and metabolic disorders ' (2008 ) 456 Methods in Molecular Biology : 1 -22.

    • Search Google Scholar
  • Winkler G., Cseh K.: Molekuláris tényezők szerepe az inzulinrezisztencia – elhízás – 2-es típusú diabetes patogenetikai kapcsolatban. Orv. Hetil., 2009, 150 , 771–780.

    Cseh K. , 'Molekuláris tényezők szerepe az inzulinrezisztencia – elhízás – 2-es típusú diabetes patogenetikai kapcsolatban ' (2009 ) 150 Orv. Hetil. : 771 -780.

    • Search Google Scholar
  • Császár A.: A zsírszövet endokrin funkciója és kapcsolata a kardiovaszkuláris kockázat kialakulásával. Cardiol. Hung., 2003, 33 , 245–250.

    Császár A. , 'A zsírszövet endokrin funkciója és kapcsolata a kardiovaszkuláris kockázat kialakulásával ' (2003 ) 33 Cardiol. Hung. : 245 -250.

    • Search Google Scholar
  • Yang, R-Z., Lee, M-J., Hu, H. és mtsai: Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am. J. Physiol. Endocrinol. Metab., 2006, 290 , E1253–E1261.

    Hu H. , 'Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action ' (2006 ) 290 Am. J. Physiol. Endocrinol. Metab. : E1253 -E1261.

    • Search Google Scholar
  • Klöting, N., Berthold, S., Kovacs, P. és mtsai: MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS ONE, 2009, 4 , e4699.

    Kovacs P. , 'MicroRNA expression in human omental and subcutaneous adipose tissue ' (2009 ) 4 PLoS ONE : e4699 -.

    • Search Google Scholar
  • Ingalls, A. M., Dickie, M. M., Snell, G. D.: Obese, new mutation in house mouse. J. Hered., 1950, 41 , 317–318.

    Snell G. D. , 'Obese, new mutation in house mouse ' (1950 ) 41 J. Hered. : 317 -318.

  • Coleman, D. L.: Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetol., 1978, 14 , 141–148.

    Coleman D. L. , 'Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice ' (1978 ) 14 Diabetol. : 141 -148.

    • Search Google Scholar
  • Friedman, J. M., Leibel, R. L., Siegel, D-S. és mtsai: Molecular mapping of the mouse ob mutation. Genomics, 1991, 11 , 1054–1062.

    Siegel D-S. , 'Molecular mapping of the mouse ob mutation ' (1991 ) 11 Genomics : 1054 -1062.

  • Zhang, Y., Proenca, R., Maffei, M. és mtsai: Positional cloning of the mouse obese gene and its human homologue. Nature, 1994, 372 , 425–432.

    Maffei M. , 'Positional cloning of the mouse obese gene and its human homologue ' (1994 ) 372 Nature : 425 -432.

    • Search Google Scholar
  • Frühbeck, G.: Intracellular signalling pathways activated by leptin. Biochem. J., 2006, 393 , 7–20.

    Frühbeck G. , 'Intracellular signalling pathways activated by leptin ' (2006 ) 393 Biochem. J. : 7 -20.

    • Search Google Scholar
  • Hegyi, K., Fülöp, K., Kovács, K. és mtsai: Leptin-induced signal transduction pathways. Cell. Biol. Internat., 2004, 28 , 159–169.

    Kovács K. , 'Leptin-induced signal transduction pathways ' (2004 ) 28 Cell. Biol. Internat. : 159 -169.

    • Search Google Scholar
  • Tartaglia, L. A., Dembski, M., Weng, X. és mtsai: Identification and expression cloning of a leptin receptor, OB-R. Cell, 1995, 83 , 1263–1271.

    Weng X. , 'Identification and expression cloning of a leptin receptor, OB-R ' (1995 ) 83 Cell : 1263 -1271.

    • Search Google Scholar
  • Knudson, J. D., Dick, G-M., Tune, J. D.: Adipokines and coronary vasomotor dysfunction. Exp. Biol. Med., 2007, 232 , 727–736.

    Tune J. D. , 'Adipokines and coronary vasomotor dysfunction ' (2007 ) 232 Exp. Biol. Med. : 727 -736.

    • Search Google Scholar
  • Sinha, M. K., Opentanova, I., Ohannesian, J. P. és mtsai: Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J. Clin. Invest., 1996, 98 , 1277–1282.

    Ohannesian J. P. , 'Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting ' (1996 ) 98 J. Clin. Invest. : 1277 -1282.

    • Search Google Scholar
  • Isidori, A. M., Strollo, F., More, M. és mtsai: Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights. J. Clin. Endocrinol. Metab., 2000, 85 , 1954–1962.

    More M. , 'Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights ' (2000 ) 85 J. Clin. Endocrinol. Metab. : 1954 -1962.

    • Search Google Scholar
  • Antal M., Regöly-Mérei A., Nagy K. és mtsai: Van-e kitüntetett mérőmódszer az elhízás megállapítására? Orv. Hetil., 2008, 149 , 1943–1948.

    Nagy K. , 'Van-e kitüntetett mérőmódszer az elhízás megállapítására? ' (2008 ) 149 Orv. Hetil. : 1943 -1948.

    • Search Google Scholar
  • Rosenbaum, M., Nicolson, M., Hirsch, J. és mtsai: Effects of gender, body composition, and menopause on plasma concentration of leptin. J. Clin. Endocrinol. Metab., 1996, 81 , 3424–3427.

    Hirsch J. , 'Effects of gender, body composition, and menopause on plasma concentration of leptin ' (1996 ) 81 J. Clin. Endocrinol. Metab. : 3424 -3427.

    • Search Google Scholar
  • Considine, R. V., Sinha, M. K., Heiman, M. L. és mtsai: Serum immunreactive leptin concentration in normal-weight and obese humans. N. Engl. J. Med., 1996, 334 , 292–295.

    Heiman M. L. , 'Serum immunreactive leptin concentration in normal-weight and obese humans ' (1996 ) 334 N. Engl. J. Med. : 292 -295.

    • Search Google Scholar
  • Zou, C., Shao, J.: Role of adipocytokines in obesity-associated insulin resistance. J. Nutr. Biochem., 2008, 19 , 277–286.

    Shao J. , 'Role of adipocytokines in obesity-associated insulin resistance ' (2008 ) 19 J. Nutr. Biochem. : 277 -286.

    • Search Google Scholar
  • Ren, J.: Leptin and hyperleptinemia – from friend to foe for cardiovascular function. J. Endocrinol., 2004, 181 , 1–10.

    Ren J. , 'Leptin and hyperleptinemia – from friend to foe for cardiovascular function ' (2004 ) 181 J. Endocrinol. : 1 -10.

    • Search Google Scholar
  • Meier, U., Gressner, A. M.: Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponektin, and resistin. Clin. Chem., 2004, 50 , 1511–1525.

    Gressner A. M. , 'Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponektin, and resistin ' (2004 ) 50 Clin. Chem. : 1511 -1525.

    • Search Google Scholar
  • Kershaw, E. E., Flier, J. S.: Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab., 2004, 89 , 2548–2556.

    Flier J. S. , 'Adipose tissue as an endocrine organ ' (2004 ) 89 J. Clin. Endocrinol. Metab. : 2548 -2556.

    • Search Google Scholar
  • Patel, S. B., Reams, G. P., Spear, R. M. és mtsai: Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease. Curr. Hypertension Rep., 2008, 10 , 131–137.

    Spear R. M. , 'Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease ' (2008 ) 10 Curr. Hypertension Rep. : 131 -137.

    • Search Google Scholar
  • Maiorana, A., Del Bianco, C., Cianfarani, S.: Adipose tissue: A metabolic regulator. Potential implications for the metabolic outcome of subjects born small for gestational age (SGA). Rev. Diabet. Stud., 2007, 4 , 134–146.

    Cianfarani S. , 'Adipose tissue: A metabolic regulator. Potential implications for the metabolic outcome of subjects born small for gestational age (SGA) ' (2007 ) 4 Rev. Diabet. Stud. : 134 -146.

    • Search Google Scholar
  • Catalán, V., Gómez-Ambrosi, J., Rodríguez, A. és mtsai: Adipokines in the treatment of diabetes mellitus and obesity. Expert. Opin. Pharmacother., 2009, 10 , 239–254.

    Rodríguez A. , 'Adipokines in the treatment of diabetes mellitus and obesity ' (2009 ) 10 Expert. Opin. Pharmacother. : 239 -254.

    • Search Google Scholar
  • de Ferranti, S., Mozafarrian, D.: The perfect storm: Obesity, adipocyte disfunction, and metabolic consequences. Clin. Chem., 2008, 54 , 945–955.

    Mozafarrian D. , 'The perfect storm: Obesity, adipocyte disfunction, and metabolic consequences ' (2008 ) 54 Clin. Chem. : 945 -955.

    • Search Google Scholar
  • Unger, R. H.: Lipotoxic diseases. Annu. Rev. Med., 2002, 53 , 319–336.

    Unger R. H. , 'Lipotoxic diseases ' (2002 ) 53 Annu. Rev. Med. : 319 -336.

  • Janečková, R.: The role of leptin in human physiology and pathophysiology. Physiol. Res., 2001, 50 , 443–459.

    Janečková R. , 'The role of leptin in human physiology and pathophysiology ' (2001 ) 50 Physiol. Res. : 443 -459.

    • Search Google Scholar
  • Kadowaki, T., Yamauchi, T.: Adiponectin and adiponectin receptors. Endocr. Rev., 2005, 26 , 439–451.

    Yamauchi T. , 'Adiponectin and adiponectin receptors ' (2005 ) 26 Endocr. Rev. : 439 -451.

  • Więcek, A., Adamczak, M., Chudek, J.: Adiponectin − an adipokine with unique metabolic properties. Nephrol. Dial. Transplant., 2007, 22 , 981–988.

    Chudek J. , 'Adiponectin − an adipokine with unique metabolic properties ' (2007 ) 22 Nephrol. Dial. Transplant. : 981 -988.

    • Search Google Scholar
  • Phillips, L. K., Prins, J. B.: The link between abdominal obesity and the metabolic syndrome. Curr. Hypertens. Rep., 2008, 10 , 156–164.

    Prins J. B. , 'The link between abdominal obesity and the metabolic syndrome ' (2008 ) 10 Curr. Hypertens. Rep. : 156 -164.

    • Search Google Scholar
  • Blüher, M., Williams, C. J., Klöting, N. és mtsai: Gene expression of adiponectin receptors in human visceral and subcutaneus adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training. Diab. Care, 2007, 30 , 3110–3115.

    Klöting N. , 'Gene expression of adiponectin receptors in human visceral and subcutaneus adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training ' (2007 ) 30 Diab. Care : 3110 -3115.

    • Search Google Scholar
  • Chandran, M., Phillips, S. A., Ciaraldi, T. és mtsa: Adiponectin: More than just another fat cell hormone? Diab. Care, 2003, 26 , 2442–2450.

    Ciaraldi T. , 'Adiponectin: More than just another fat cell hormone? ' (2003 ) 26 Diab. Care : 2442 -2450.

    • Search Google Scholar
  • Fehér J., Lengyel G.: Roziglitazon és glimepirid kombinációs készítmény klinikai alkalmazása 2-es típusú diabetes mellitus kezelésében. Orv. Hetil., 2007, 148 , 2331–2335.

    Lengyel G. , 'Roziglitazon és glimepirid kombinációs készítmény klinikai alkalmazása 2-es típusú diabetes mellitus kezelésében ' (2007 ) 148 Orv. Hetil. : 2331 -2335.

    • Search Google Scholar
  • Steppan, C. M., Brown, E. J., Wright, C. M. és mtsai: A family of tissue-specific resistin-like molecules. Proc. Natl. Acad. Sci. USA, 2001, 98 , 502–506.

    Wright C. M. , 'A family of tissue-specific resistin-like molecules ' (2001 ) 98 Proc. Natl. Acad. Sci. USA : 502 -506.

    • Search Google Scholar
  • Gómez-Ambrosi, J., Frühbeck, G.: Evidence for the involvement of resistin in inflammation and cardiovascular disease. Curr. Diab. Rev., 2005, 1 , 227–234.

    Frühbeck G. , 'Evidence for the involvement of resistin in inflammation and cardiovascular disease ' (2005 ) 1 Curr. Diab. Rev. : 227 -234.

    • Search Google Scholar
  • Gerber, M., Boettner, A., Seidel, B. és mtsai: Serum resistin levels of obese and lean children and adolescents: Biochemical analysis and clinical relevance. J. Clin. Endocrinol. Metab., 2005, 90 , 4503–4509.

    Seidel B. , 'Serum resistin levels of obese and lean children and adolescents: Biochemical analysis and clinical relevance ' (2005 ) 90 J. Clin. Endocrinol. Metab. : 4503 -4509.

    • Search Google Scholar
  • Antal M., Regöly-Mérei A., Biró L. és mtsai: Az oligofruktóz hatásának vizsgálata elhízottakban. Orv. Hetil., 2008, 149 , 1989–1995.

    Biró L. , 'Az oligofruktóz hatásának vizsgálata elhízottakban ' (2008 ) 149 Orv. Hetil. : 1989 -1995.

    • Search Google Scholar
  • Rabe, K., Lehrke, M., Parhofer, K. G. és mtsa: Adipokines and insulin resistance. Mol. Med., 2008, 14 , 741–751.

    Parhofer K. G. , 'Adipokines and insulin resistance ' (2008 ) 14 Mol. Med. : 741 -751.

  • Lee, W-J., Wu, C-S., Lin, H. és mtsai: Visfatin-induced expression of inflammatory mediators in human endothelial cells through the NF-κB pathway Visfatin-induced expression of inflammatory mediators. Int. J. Obes., 2009, 33 , 465–472.

    Lin H. , 'Visfatin-induced expression of inflammatory mediators in human endothelial cells through the NF-κB pathway Visfatin-induced expression of inflammatory mediators ' (2009 ) 33 Int. J. Obes. : 465 -472.

    • Search Google Scholar
  • Luk, T., Malam, Z., Marshall, J. C.: Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity. J. Leukoc. Biol., 2008, 83 , 804–816.

    Marshall J. C. , 'Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity ' (2008 ) 83 J. Leukoc. Biol. : 804 -816.

    • Search Google Scholar
  • Sun, G., Bishop, J., Khalili, S. és mtsai: Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men. Am. J. Clin. Nutr., 2007, 85 , 399–404.

    Khalili S. , 'Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men ' (2007 ) 85 Am. J. Clin. Nutr. : 399 -404.

    • Search Google Scholar
  • Zhu, J., Schott, M., Liu, R. és mtsai: Intensive glycemic control lowers plasma visfatin levels in patients with type 2 diabetes. Horm. Metab. Res., 2008, 40 , 801–805.

    Liu R. , 'Intensive glycemic control lowers plasma visfatin levels in patients with type 2 diabetes ' (2008 ) 40 Horm. Metab. Res. : 801 -805.

    • Search Google Scholar
  • Haider, D. G., Holzer, G., Schaller, G. és mtsai: The adipokine visfatin is markedly elevated in obese children. J. Ped. Gastroenterol. Nutr., 2006, 43 , 548–549.

    Schaller G. , 'The adipokine visfatin is markedly elevated in obese children ' (2006 ) 43 J. Ped. Gastroenterol. Nutr. : 548 -549.

    • Search Google Scholar
  • Chang, Y-C., Chang, T-J., Lee, W-J. és mtsa: The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids. Metabolism – Clin. Exp., 2010, 59 , 93–99.

    Lee W-J. , 'The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids ' (2010 ) 59 Metabolism – Clin. Exp. : 93 -99.

    • Search Google Scholar
  • BioVendor: Omentin. BioVendor R&D News:1. 7. 2008, http://news.biovendor.com/article/omentin

  • De Souza Batista, C. M., Yang, R. Z., Lee, M. J. és mtsai: Omentin plasma levels and gene expression are decreased in obesity. Diabetes, 2007, 56 , 1655–1881.

    Lee M. J. , 'Omentin plasma levels and gene expression are decreased in obesity ' (2007 ) 56 Diabetes : 1655 -1881.

    • Search Google Scholar
  • Pan, H-Y., Guo, L., Li, Q.: Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diab. Res. Clin., 2010, 88 , 29–33.

    Li Q. , 'Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes ' (2010 ) 88 Diab. Res. Clin. : 29 -33.

    • Search Google Scholar